WST - West Pharmaceutical Services Inc Stock Price, Fair Value and News

$320.71-0.17 (-0.05%)

Delayed as of 22 Nov 2024, 12:18 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

WST Price Action

Last 7 days

-5.1%

Last 30 days

12.0%

Last 90 days

6.0%

Trailing 12 Months

-8.6%

WST RSI Chart

WST Valuation

Market Cap

23.2B

Price/Earnings (Trailing)

46.51

Price/Sales (Trailing)

8.08

EV/EBITDA

30.94

Price/Free Cashflow

72.26

WST Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

WST Fundamentals

WST Revenue

Revenue (TTM)

2.9B

Rev. Growth (Yr)

-0.07%

Rev. Growth (Qtr)

6.38%

WST Earnings

Earnings (TTM)

499.6M

Earnings Growth (Yr)

-15.69%

Earnings Growth (Qtr)

22.19%

WST Profitability

EBT Margin

20.47%

Return on Equity

18.15%

Return on Assets

13.59%

Free Cashflow Yield

1.38%

WST Investor Care

Dividend Yield

0.24%

Dividend/Share (TTM)

0.78

Buy Backs (1Y)

2.12%

Diluted EPS (TTM)

6.74

WST Alerts

1 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.9B	2.9B	2.9B	0
2023	2.9B	2.9B	2.9B	2.9B
2022	2.9B	2.9B	2.9B	2.9B
2021	2.3B	2.5B	2.7B	2.8B
2020	1.9B	1.9B	2.0B	2.1B
2019	1.7B	1.8B	1.8B	1.8B
2018	1.6B	1.7B	1.7B	1.7B
2017	1.5B	1.5B	1.6B	1.6B
2016	1.4B	1.5B	1.5B	1.5B
2015	1.4B	1.4B	1.4B	1.4B
2014	1.4B	1.4B	1.4B	1.4B
2013	1.3B	1.3B	1.3B	1.4B
2012	1.2B	1.2B	1.2B	1.3B
2011	1.1B	1.2B	1.2B	1.2B
2010	1.1B	1.1B	1.1B	1.1B
2009	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

CEO	Mr. Eric M. Green
WEBSITE	westpharma.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	10700

West Pharmaceutical Services Inc Frequently Asked Questions

What is the ticker symbol for West Pharmaceutical Services Inc? What does WST stand for in stocks?

WST is the stock ticker symbol of West Pharmaceutical Services Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of West Pharmaceutical Services Inc (WST)?

As of Thu Nov 21 2024, market cap of West Pharmaceutical Services Inc is 23.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of WST stock?

You can check WST's fair value in chart for subscribers.

Is West Pharmaceutical Services Inc a good stock to buy?

The fair value guage provides a quick view whether WST is over valued or under valued. Whether West Pharmaceutical Services Inc is cheap or expensive depends on the assumptions which impact West Pharmaceutical Services Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for WST.

What is West Pharmaceutical Services Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, WST's PE ratio (Price to Earnings) is 46.51 and Price to Sales (PS) ratio is 8.08. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. WST PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on West Pharmaceutical Services Inc's stock?

In the past 10 years, West Pharmaceutical Services Inc has provided 0.199 (multiply by 100 for percentage) rate of return.